Marcus Trent@VeronicaManzAlb
$TNXP — Tonix Pharmaceuticals Holding Corp.
TNXP is a clinical-stage biopharmaceutical company with a pipeline including products for migraines, fibromyalgia, PTSD, and vaccines. With clinical progress and potential approvals, TNXP is poised for breakthroughs in rare/central nervous system diseases. However, its early-stage development, significant losses, and high clinical/regulatory risks have led to extreme stock price volatility (recently experiencing a pullback followed by consolidation).
Technical Analysis and Trading
Current Price: $14.19
Key Support Levels: $13.50–$14.00
Resistance Levels: $15.00–$16.00
Strategy
Buying Range: $13.80–$14.50
Build positions in stages, gradually increasing the position after a pullback confirms support levels.
Target Price
First Target Price: $18–$20
Second Target Price: $25+
TNXP benefits from the biotechnology and pipeline progress themes, resulting in significant short-term price volatility. However, long-term performance depends on clinical data. Suitable for high-risk biotech investors to build positions in stages, focusing on trial results and milestones.
👉 If you wish to get ahead of market trends, or if you are a new follower, please click the contact number listed on my profile page to add me as a contact on WhatsApp. I will share with you the exclusive, original market insights that I publish within my private group.
#SP500
#SPY
#QQQ
#TNXP
#StockMarket
#StockTrading
$NVDA
$TSLA
$AMD